The Lung Center of the Philippines is a government tertiary hospital specializing in the cure and prevention of lung and other chest diseases, located on Central, Quezon City, Philippines. The center receives budgetary support for its operations from the national government.

There are 210 beds in Lung Center of the Philippines.

During the past decade, Lung Center of the Philippines conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 5 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lung Center of the Philippines" #1 sponsor was "Global Alliance for TB Drug Development" with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "National University Hospital, Singapore" with 2 trials sponsored, "Agennix" with 1 trials sponsored and "Algernon Pharmaceuticals" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lung Center of the Philippines" #1 collaborator was "Novotech (Australia)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Lung Center of the Philippines" are "Covid19" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Coronavirus Disease (COVID-19)" (2 trials), "Pulmonary Tuberculosis" (2 trials) and "COVID" (1 trials). Many other conditions were trialed in "Lung Center of the Philippines" in a lesser frequency.

Most popular intervention types in "Lung Center of the Philippines" are "Drug" (15 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pyrazinamide" (3 trials), "Molnupiravir" (2 trials), "Moxifloxacin" (2 trials) and "Rifampicin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Lung Center of the Philippines" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Lung Center of the Philippines". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Lung Center of the Philippines, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Lung Center of the Philippines, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".